| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9326308 | Gynecologic Oncology | 2005 | 7 Pages |
Abstract
We showed that COX-2 expression is not correlated with ER, PR, p53, and neu, thus suggesting that COX-2-mediated activities may follow independent pathways. Our findings provide the rationale to design trials based on the combination of antihormones with inhibitors of COX-2 and neu in recurrent/metastatic endometrial cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Gabriella Ferrandina, Franco Oreste Ranelletti, Valerio Gallotta, Enrica Martinelli, Gian Franco Zannoni, Marco Gessi, Giovanni Scambia,